Could TB treatment be cut from 6 months to 8 weeks? major trial launches
NCT ID NCT06114628
First seen Nov 01, 2025
Summary
This study tests new drug combinations to treat pulmonary tuberculosis (TB) faster than the standard 24-week regimen. About 2500 adults with TB will receive one of several experimental combinations, including two new drugs (BTZ-043 and GSK3036656), for 8 to 16 weeks. Researchers aim to find a shorter, equally safe and effective treatment that could also work for drug-resistant TB.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Joint Clinical Research Centre
RECRUITINGKampala, Uganda
Contact
-
Kibong'oto Infectious Diseases Hospital
RECRUITINGMoshi, Tanzania
Contact
-
Makerere University Lung Institute
RECRUITINGKampala, Uganda
Contact
-
NIMR Mbeya
RECRUITINGMbeya, Tanzania
Contact
-
NIMR Mwanza
RECRUITINGMwanza, Tanzania
Contact
-
National Lung Hospital
ACTIVE_NOT_RECRUITINGHanoi, Vietnam
-
PMSI Institute of Pneumology "Chiril Draganiuc"
ACTIVE_NOT_RECRUITINGChisinau, Moldova
-
Pnth/Oucru
ACTIVE_NOT_RECRUITINGHo Chi Minh City, Vietnam
-
TASK Brooklyn
RECRUITINGCape Town, South Africa
Contact
-
TASK Eden
RECRUITINGGeorge, South Africa
Contact
-
University of Cape Town Lung Institute
RECRUITINGCape Town, South Africa
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.